Vectibix 100mg

Vectibix 100mg injection is an anticancer medication classified as an epidermal growth factor receptor (EGFR) inhibitor, containing Panitumumab as its active ingredient. It is indicated for the treatment of metastatic colorectal cancer, which originates in the colon or rectum and has metastasized to other areas of the body.

This injection should not be administered if you have an allergy to any of its components. The drug targets specific proteins in the body, potentially increasing the risk of bleeding. If you notice any signs of bleeding while using this medication, such as unusual bruising, black or tarry stools, blood in urine, or bleeding gums, it is crucial to contact your physician immediately. Your doctor may need to modify your dosage or temporarily halt the treatment. Eye issues may arise during treatment with this drug, including inflammation and corneal damage, with symptoms that may involve eye pain, redness, blurred vision, and light sensitivity.

It is essential to inform your doctor if you encounter any skin issues while on this medication. Your physician may suggest topical creams or ointments for skin relief or prescribe antibiotics for any infections that may arise. Infusion reactions, which are allergic responses that can occur during or shortly after the medication infusion, may also occur as a side effect of this drug. To reduce the likelihood of such reactions, your doctor will closely monitor you during and after the infusion and may administer medications like antihistamines and corticosteroids to prevent or address any allergic reactions that may happen. Vectibix 100mg injection is contraindicated during pregnancy due to potential harm to the fetus. Inform your healthcare provider before starting this treatment if you are pregnant or planning to conceive. It is recommended for both men and women to use effective contraceptive methods during treatment and for three months following the last dose of the medication.